Publications by authors named "Signe Risum"

Claim this Profile
A
Accuracy and consistency of intensity-based deformable image registration in 4DCT for tumor motion estimation in liver radiotherapy planning.
José D Tascón-Vidarte, Line Bjerregaard Stick, Mirjana Josipovic, Signe Risum, Julien Jomier

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Kristin Toftaker Killingberg, Tarje Onsøien Halvorsen, Øystein Fløtten, Odd Terje Brustugun, Seppo W Langer, Signe Risum

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
Bjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, Odd Terje Brustugun, Kjersti Hornslien, Signe Risum

Lancet Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrafractional fiducial marker position variations in stereotactic liver radiotherapy during voluntary deep inspiration breath-hold.
Line Bjerregaard Stick, Ivan Richter Vogelius, Signe Risum, Mirjana Josipovic

Br J Radiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hitherto unseen survival in an ALK-positive-patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine.
Signe Risum, Ulrich Knigge, Seppo W Langer

Clin Case Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and survival from lung cancer in Greenland is comparable to survival in the Nordic countries.
Allan Gelvan, Signe Risum, Seppo W Langer

Dan Med J· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography/computed tomography predictors of overall survival in stage IIIC/IV ovarian cancer.
Signe Risum, Annika Loft, Svend Aage Engelholm, Estrid Høgdall, Anne Kiil Berthelsen

Int J Gynecol Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer.
Claus Høgdall, Eric T Fung, Ib J Christensen, Lotte Nedergaard, Svend A Engelholm, Signe Risum

Gynecol Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized FDG uptake as a prognostic variable and as a predictor of incomplete cytoreduction in primary advanced ovarian cancer.
Signe Risum, Annika Loft, Claus Høgdall, Anne K Berthelsen, Estrid Høgdall

Acta Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients.
Estrid Høgdall, Eric T Fung, Ib Jarle Christensen, Christine Yip, Lotte Nedergaard, Signe Risum

Proteomics Clin Appl· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis.
Anette Lykke Petri, Anja Hviid Simonsen, Estrid Høgdall, Ib Jarle Christensen, Susanne Krüger Kjaer, Signe Risum

Proteomics Clin Appl· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proteomics panel for predicting optimal primary cytoreduction in stage III/IV ovarian cancer.
Signe Risum, Estrid Høgdall, Svend A Engelholm, Eric Fung, Lee Lomas

Int J Gynecol Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography on recurrent ovarian cancer diagnosis and on selection of patients for secondary cytoreductive surgery.
Signe Risum, Claus Høgdall, Elena Markova, Anne K Berthelsen, Annika Loft

Int J Gynecol Cancer· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.
Signe Risum, Claus Høgdall, Annika Loft, Anne K Berthelsen, Estrid Høgdall

Gynecol Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Signe Risum, Seppo W Langer

Ugeskr Laeger· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis